Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study

ConclusionThe care pathway for children with JIA can be expensive, and complex —and varies by JIA subtype. Although the yearly total mean cost per patient was constant, the distribution of costs changes over time with the introduction of biologic therapies later in the care pathway. This study provides a better understanding of the JIA costs profile and can help inform futur e economic studies.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research